FINASTERIDE
Manner of administration:Oral
Restriction
Indication: Benign prostatic hyperplasia
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 56 | # of repeats: 5 | DPMQ: - | Max safety net: - | General Patient Charge: - |
| Available brands | |||||
| Finpro | DPMQ: $166.48 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
Manner of administration:Oral
Restriction
Indication: Benign prostatic hyperplasia
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: - | Max safety net: - | General Patient Charge: - |
| Available brands | |||||
|
|
DPMQ: $186.58 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $186.58 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $186.58 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $141.34 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $141.34 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $141.34 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $177.70 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $186.58 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $186.58 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
Manner of administration:Oral
Restriction
Indication: Benign prostatic hyperplasia
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: - | Max safety net: - | General Patient Charge: - |
| Available brands | |||||
|
|
DPMQ: $98.75 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $98.75 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $98.75 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $77.21 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $77.21 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $77.21 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $94.52 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $98.75 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
|
|
DPMQ: $98.75 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
Manner of administration:Oral
Restriction
Indication: Benign prostatic hyperplasia
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 28 | # of repeats: 5 | DPMQ: - | Max safety net: - | General Patient Charge: - |
| Available brands | |||||
| Finpro | DPMQ: $89.18 | Max safety net: $7.70 | General Patient Charge: $7.70 | ||
